August 4, 2020
Ruben A. Mesa, MD, director of the Mays Cancer Center, discusses the potential utility of CAR T-cell therapy in myeloproliferative neoplasms (MPNs) in this video. Watch the interview.
July 24, 2020
The new COVID-19 and Cancer Consortium study shows that patients who were treated with the antiviral drug remdesivir fared the best.
July 23, 2020
In this video, Ruben A. Mesa, MD, director of the Mays Cancer Center at UT Health San Antonio MD Anderson Cancer Center, discusses the potential clinical benefit of rechallenging with JAK inhibitor therapy in patients with myeloproliferative neoplasms (MPNs). Watch the interview.
July 20, 2020
Ruben Mesa, MD, director of the Mays Cancer Center, discusses recent data with momelotinib in myelofibrosis. Read and watch the story.
July 16, 2020
New insights into Ewing sarcoma, an aggressive childhood cancer, were published July 15 in the prestigious journal Nature.
July 13, 2020
Dr. Ruben Mesa, Mays Cancer Center Director, contributes to The Cancer Letter’s ongoing coverage of COVID-19’s impact on oncology. Read the story.